Karopadi Shivanand Nayak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karopadi Shivanand Nayak has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
S.V. Subhramanyam
5 shared publicationsSinoj Antony
Virinchi Hosp, Dept Nephrol, Hyderabad 500034, India
3 shared publicationsAkash Nayak Karopadi
Dr Nayak Dialysis Center, Hyderabad, India
2 shared publicationsK.A. Sinoj
2 shared publicationsA Nayak
1 shared publicationA. N. Karopadi
1 shared publication
Latest Publications
- Open Access
- 8 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8717
Allo-Hemodialysis: A Narrative Review of a Novel Approach to Resource-Sparing Kidney Replacement Therapy
Conventional hemodialysis (HD) is one of the most resource-intensive therapies in medicine and remains inaccessible to a large share of the world’s population with kidney failure. Allo-hemodialysis (alloHD) is a novel hemodialysis concept in which the blood of a healthy volunteer (“buddy”) replaces manufactured dialysate, flowing counter-currently to the patient’s blood across a conventional dialyzer membrane. Uremic solutes and excess fluid move from the patient into the buddy’s circulation and are cleared by the buddy’s own kidneys, while bicarbonate and water-soluble vitamins diffuse back to the patient. By eliminating water treatment, dialysate production, and much of a conventional machine’s electromechanical complexity, alloHD has the potential to lower the cost, complexity, and environmental footprint of kidney replacement therapy. This review synthesizes the evidence for alloHD, spanning two-compartment urea and acid–base kinetic modeling, ex vivo bench testing of a low-cost prototype, and in vivo porcine studies of acute kidney injury, while describing a modeling extension to severe neonatal jaundice. We summarize buddy safety considerations as well as review ethical issues and caregiver/health-care professional acceptance data. Finally, we position alloHD within the broader movement toward more sustainable and personalized dialysis, and outline the translational steps required before first-in-human study.
- 8 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8717
Open AccessAllo-Hemodialysis: A Narrative Review of a Novel Approach to Resource-Sparing Kidney Replacement Therapy
Conventional hemodialysis (HD) is one of the most resource-intensive therapies in medicine and remains inaccessible to a large share of the world’s population with kidney failure. Allo-hemodialysis (alloHD) is a novel hemodialysis concept in which the blood of a healthy volunteer (“buddy”) replaces manufactured dialysate, flowing counter-currently to the patient’s blood across a conventional dialyzer membrane. Uremic solutes and excess fluid move from the patient into the buddy’s circulation and are cleared by the buddy’s own kidneys, while bicarbonate and water-soluble vitamins diffuse back to the patient. By eliminating water treatment, dialysate production, and much of a conventional machine’s electromechanical complexity, alloHD has the potential to lower the cost, complexity, and environmental footprint of kidney replacement therapy. This review synthesizes the evidence for alloHD, spanning two-compartment urea and acid–base kinetic modeling, ex vivo bench testing of a low-cost prototype, and in vivo porcine studies of acute kidney injury, while describing a modeling extension to severe neonatal jaundice. We summarize buddy safety considerations as well as review ethical issues and caregiver/health-care professional acceptance data. Finally, we position alloHD within the broader movement toward more sustainable and personalized dialysis, and outline the translational steps required before first-in-human study.
- 1 January 2020
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 93 (1) , 94-99
Application of new innovations/technology for care of end-stage renal disease in a resource-limited environment
The costs involved in the management of end-stage renal disease (ESRD) patients are overwhelming the healthcare commitments of countries worldwide and even more so in resource-limited settings. Some countries have intelligently managed to implement universal healthcare coverage for their citizens. Many others, unable to achieve this, have sensibly concentrated on spending their limited resources on less expensive but more important healthcare issues, such as preventive care especially in the areas of waterborne diseases and implementation of universal vaccination. This however leaves a large section of the population with ESRD vulnerable, and it is up to the various stakeholders, including the medical professions, to innovate and partly alleviate their suffering as a social responsibility.
- 1 January 2020
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 93 (1) , 94-99
Application of new innovations/technology for care of end-stage renal disease in a resource-limited environment
The costs involved in the management of end-stage renal disease (ESRD) patients are overwhelming the healthcare commitments of countries worldwide and even more so in resource-limited settings. Some countries have intelligently managed to implement universal healthcare coverage for their citizens. Many others, unable to achieve this, have sensibly concentrated on spending their limited resources on less expensive but more important healthcare issues, such as preventive care especially in the areas of waterborne diseases and implementation of universal vaccination. This however leaves a large section of the population with ESRD vulnerable, and it is up to the various stakeholders, including the medical professions, to innovate and partly alleviate their suffering as a social responsibility.
- 1 August 2016
- Published by Indian Journal of Peritoneal Dialysis in Indian Journal of Peritoneal dialysis
- Vol. 31, 31
Treating Severe Hyponatremia and Renal Failure with Automated Peritoneal Dialysis
Severe hyponatremia and renal failure requiring renal replacement therapy pose a therapeutic challenge. Hemodialysis to correct volume overload, azotemia, and abnormal electrolyte levels will result in rapid correction of serum sodium concentration and place the patient at risk for osmotic demyelination syndrome. We present a patient with acute kidney injury and severe hypotonic hyponatremia (serum sodium<115 mEq/L) who was treated successfully with Automated Peritoneal Dialysis(APD).Previous experiences of using continuous venovenous hemofiltration successfully have been documented,,where sodium correction rate is regulated by intricate single pool sodium kinetic modelling, but there are no reports of peritoneal dialysis in these situations. In our case, bedside Tenchoff catheter placement and cycler PD used. We found that APD can be a cost effective safe, accurate and easy alternate treatment in combined hyponatremia and renal failure requiring dialysis.
- 1 August 2016
- Published by Indian Journal of Peritoneal Dialysis in Indian Journal of Peritoneal dialysis
- Vol. 31, 31
Treating Severe Hyponatremia and Renal Failure with Automated Peritoneal Dialysis
Severe hyponatremia and renal failure requiring renal replacement therapy pose a therapeutic challenge. Hemodialysis to correct volume overload, azotemia, and abnormal electrolyte levels will result in rapid correction of serum sodium concentration and place the patient at risk for osmotic demyelination syndrome. We present a patient with acute kidney injury and severe hypotonic hyponatremia (serum sodium<115 mEq/L) who was treated successfully with Automated Peritoneal Dialysis(APD).Previous experiences of using continuous venovenous hemofiltration successfully have been documented,,where sodium correction rate is regulated by intricate single pool sodium kinetic modelling, but there are no reports of peritoneal dialysis in these situations. In our case, bedside Tenchoff catheter placement and cycler PD used. We found that APD can be a cost effective safe, accurate and easy alternate treatment in combined hyponatremia and renal failure requiring dialysis.
- 1 July 2016
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 36 (4) , 362-366
Telemedicine and Remote Monitoring: Supporting the Patient on Peritoneal Dialysis
- 1 July 2016
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 36 (4) , 362-366
Telemedicine and Remote Monitoring: Supporting the Patient on Peritoneal Dialysis
- 1 October 2014
- Published by Elsevier in Hong Kong Journal of Nephrology
- Vol. 16 (2) , 34-41
Treatment of chronic kidney disease patients with ketoanalogue-supplemented low-protein diet and ketoanalogue-supplemented very-low-protein diet
- 1 October 2014
- Published by Elsevier in Hong Kong Journal of Nephrology
- Vol. 16 (2) , 34-41
Treatment of chronic kidney disease patients with ketoanalogue-supplemented low-protein diet and ketoanalogue-supplemented very-low-protein diet
- 1 April 2013
- Published by Elsevier in Hong Kong Journal of Nephrology
- Vol. 15 (1) , 6-13
Remote monitoring of peritoneal dialysis: Why? Where? How?
- 1 April 2013
- Published by Elsevier in Hong Kong Journal of Nephrology
- Vol. 15 (1) , 6-13
Remote monitoring of peritoneal dialysis: Why? Where? How?
- Open Access
- 1 June 2012
- Published by Elsevier in Kidney Research and Clinical Practice
- Vol. 31 (2) , A61
Treatment Of Chronic Kidney Disease Patients With A Supplemented Low Protein Diet And A Supplemented Very Low Protein Diet
- 1 June 2012
- Published by Elsevier in Kidney Research and Clinical Practice
- Vol. 31 (2) , A61
Open AccessTreatment Of Chronic Kidney Disease Patients With A Supplemented Low Protein Diet And A Supplemented Very Low Protein Diet
- 1 March 2012
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 32 (2) , 200-204
Use of a Peritoneal Dialysis Remote Monitoring System in India
- 1 March 2012
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 32 (2) , 200-204
Use of a Peritoneal Dialysis Remote Monitoring System in India
- 1 January 2009
- Published by S. Karger AG
- Vol. 163, 270-277
Peritoneal Dialysis in Developing Countries
Peritoneal dialysis (PD) is acknowledged worldwide as a well-accepted form of renal replacement therapy (RRT) for end-stage renal disease (ESRD). Ideally, PD should be the preferred modality of RRT for ESRD in developing countries due to its many inherent advantages. Some of these are cost savings (especially if PD fluids are manufactured locally or in a neighboring country), superior rehabilitation and quality of life (QOL), home-based therapy even in rural settings, avoidance of hospital based treatment and the need for expensive machinery, and freedom from serious infections (hepatitis B and C). However, this is not the ground reality, due to certain preconceived notions of the health care givers and governmental agencies in these countries. With an inexplicable stagnation or decline of PD numbers in the developed world, the future of PD will depend on its popularization in Latin America and in Asia especially countries such as China and India, with a combined population of 2.5 billion and the two fastest growing economies worldwide. A holistic approach to tackle the issues in the developing countries, which may vary from region to region, is critical in popularizing PD and establishing PD as the first-choice RRT for ESRD. At our center, we have been pursuing a 'PD first' policy and promoting PD as the therapy of choice for various situations in the management of renal failure. We use certain novel strategies, which we hope can help PD centers in other developing countries working under similar constraints. The success of a PD program depends on a multitude of factors that are interlinked and inseparable. Each program needs to identify its strengths, special circumstances, and deficiencies, and then to strategize accordingly. Ultimately, teamwork is the 'mantra' for a successful outcome, the patient being central to all endeavors. A belief and a passion for PD are the fountainhead and cornerstone on which to build a quality PD program.
- 1 January 2009
- Published by S. Karger AG
- Vol. 163, 270-277
Peritoneal Dialysis in Developing Countries
Peritoneal dialysis (PD) is acknowledged worldwide as a well-accepted form of renal replacement therapy (RRT) for end-stage renal disease (ESRD). Ideally, PD should be the preferred modality of RRT for ESRD in developing countries due to its many inherent advantages. Some of these are cost savings (especially if PD fluids are manufactured locally or in a neighboring country), superior rehabilitation and quality of life (QOL), home-based therapy even in rural settings, avoidance of hospital based treatment and the need for expensive machinery, and freedom from serious infections (hepatitis B and C). However, this is not the ground reality, due to certain preconceived notions of the health care givers and governmental agencies in these countries. With an inexplicable stagnation or decline of PD numbers in the developed world, the future of PD will depend on its popularization in Latin America and in Asia especially countries such as China and India, with a combined population of 2.5 billion and the two fastest growing economies worldwide. A holistic approach to tackle the issues in the developing countries, which may vary from region to region, is critical in popularizing PD and establishing PD as the first-choice RRT for ESRD. At our center, we have been pursuing a 'PD first' policy and promoting PD as the therapy of choice for various situations in the management of renal failure. We use certain novel strategies, which we hope can help PD centers in other developing countries working under similar constraints. The success of a PD program depends on a multitude of factors that are interlinked and inseparable. Each program needs to identify its strengths, special circumstances, and deficiencies, and then to strategize accordingly. Ultimately, teamwork is the 'mantra' for a successful outcome, the patient being central to all endeavors. A belief and a passion for PD are the fountainhead and cornerstone on which to build a quality PD program.
- Open Access
- 1 June 2007
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 27 (2_suppl) , 27-31
Our Experience of Home Visits in City and Rural Areas
In a peritoneal dialysis (PD) program, an efficient and well-structured home visit schedule is imperative for ensuring patient compliance, adherence to proper exchange technique, nutrition status monitoring and intervention, and early detection of evolving medical co-morbid problems so as to prevent further complications. Regular home-visit follow-up of the PD patient directly affects technique survival and quality of life. The clinical coordinator is ideally placed to be the direct link between the PD center and patients in their domiciliary surroundings. This professional plays a crucial role in the success of a PD program.
- 1 June 2007
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 27 (2_suppl) , 27-31
Open AccessOur Experience of Home Visits in City and Rural Areas
In a peritoneal dialysis (PD) program, an efficient and well-structured home visit schedule is imperative for ensuring patient compliance, adherence to proper exchange technique, nutrition status monitoring and intervention, and early detection of evolving medical co-morbid problems so as to prevent further complications. Regular home-visit follow-up of the PD patient directly affects technique survival and quality of life. The clinical coordinator is ideally placed to be the direct link between the PD center and patients in their domiciliary surroundings. This professional plays a crucial role in the success of a PD program.